Fecal Shedding of SARS-CoV-2 Outlasts That of Respiratory Tract
A timeline for fecal viral shedding of COVID-19 has been published in Gastroenterology.
General Gastroenterology
GENERAL GASTROENTEROLOGY
Feature
Latest News
Antiobesity Medications May Curb Weight Regain After RYGB
The antiobesity medications phentermine and topiramate may help mitigate weight regain after Roux-en-Y gastric bypass surgery.
Effects of the COVID-19 Pandemic on North American Gastroenterology and Endoscopy Practices
In response to the COVID-19 pandemic, a number of North American gastroenterology institutions have implemented changes to clinical practice.
Mental Health Symptoms Up for Medics Dealing With COVID-19
The scores for mental health symptoms in medical personnel responding to COVID-19 pneumonia are generally higher than the norm in China.
Evidence Supporting Dietary Supplement Use for COVID-19 Lacking
There is a lack of evidence supporting the use of dietary supplements for the prevention or treatment of COVID-19, despite what recent news or social media platforms have asserted,
US Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research
Deal will fund phase 3 clinical trial in the United States this summer with about 30,000 volunteers
CDC Looks at Transmission of COVID-19 to Health Care Workers
Thirty-seven HCP who were tested for SARS-CoV-2 were interviewed, including three who tested positive.
Qinlock Approved As Fourth-Line Treatment of Advanced GI Stromal Tumors
The FDA has approved Qinlock™ (ripretinib; Deciphera) for the treatment of adults with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
28 Million-Plus Surgeries Could Be Canceled Due to COVID-19
Worldwide, more than 28 million elective surgeries could be canceled or postponed during the 12 weeks of peak disruption due to COVID-19.
Link Found Between Body Size in Childhood, Later Life Disease
Large adult body size contributes to the association between genetically predicted larger body size in childhood and coronary artery disease and type 2 diabetes later in life.
Long Work Hours Linked to Greater Risk for Hypothyroidism
Increased weekly working hours are associated with a higher risk for hypothyroidism in workers with no evidence of thyroid autoimmunity.
COVID-19: Atypical GI Presentations
There are increasing data to support that many patients with COVID-19 can develop a myriad of gastrointestinal symptoms, which include mild diarrhea, nausea, vomiting and abdominal pain.
Transdermal Granisetron an Option for High-Risk CINV, Poor Adherence to Oral Antiemetics
A prospective study demonstrated this treatment is an option for patients undergoing chemoradiation for gynecologic cancers who are at risk of late-onset CINV or noncompliance with oral therapy.
Convalescent Plasma as Treatment for COVID-19
All 6 patients who received treatment with convalescent plasma subsequently tested negative for SARS-CoV-2.
Higher BMI Associated With Greater Risk of Colorectal Cancer
Higher body mass index (BMI) is associated with increased risk of colorectal cancer, more so for men than for women.
FDA Slashes Number of Approved Chinese Makers of N95 Masks
The number of mask makers in China approved to make N95-type masks for US health care workers was slashed from 80 to 14 by the US Food and Drug Administration.
Long-Term Green Tea Extract Supplementation May Improve Lipid Profile in T2D
Supplementary intake of green tea extract for >8 weeks may improve triglyceride and cholesterol levels in individuals with type 2 diabetes.
Fiber Supplements Recalled Due to Possible Plastic Contamination
GlaxoSmithKline (GSK) Consumer Healthcare is voluntarily recalling 5 lots of Benefiber Healthy Shape Prebiotic Fiber Supplement powder and Benefiber Prebiotic Fiber Supplement powder due possible plastic contamination. According to the Company, it is possible that the products may contain green plastic pieces or shavings from the bottle cap.
Most Jurisdictions Report COVID-19 in Correctional Facilities
At least one laboratory-confirmed COVID-19 case has been reported in correctional and detention facilities in 86 percent of 54 state and territorial health department jurisdictions.
Changes to Normal Gastrointestinal Care During the COVID-19 Pandemic
The COVID-19 pandemic has caused physicians in the New York area to reevaluate how they care for patients with gastrointestinal (GI) diseases.
Microbiome-Based Therapy Looks Promising for Recurrent C. Difficile Infection
“These positive preliminary findings represent a major step forward towards bringing an innovative, non-antibiotic option to patients that may help restore their gut microbiome,” said Per Falk, Ferring’s President and Chief Science Officer.
Want to read more?
Please login or register first to view this content.
Next post in General Gastroenterology
